Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 12
Submit an article Journal homepage
597
Views
12
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy

Hiromichi TakahashiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan; ;Division of Laboratory Medicine, Department of Pathology of Microbiology, Nihon University School of Medicine, Tokyo, Japan;
,
Katsuhiro MiuraDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan; Correspondence[email protected] [email protected]
,
Masaru NakagawaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Masahiko SugitaniDepartment of Pathology, Nihon University School of Medicine, Tokyo, Japan
,
Yusuke AmanoDepartment of Pathology, Nihon University School of Medicine, Tokyo, Japan
,
Daisuke KuritaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Masashi SakagamiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Shimon OhtakeDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Yoshihito UchinoDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Hitomi KodairaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Noriyoshi IriyamaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Sumiko KobayashiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Atsuko HojoDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Yujin KobayashiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Yukio HirabayashiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Machiko KusudaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
,
Yoshihiro HattaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan; Correspondence[email protected] [email protected]
,
Tomohiro NakayamaDivision of Laboratory Medicine, Department of Pathology of Microbiology, Nihon University School of Medicine, Tokyo, Japan;
&
Masami TakeiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
show all
Pages 2784-2790 | Received 01 Oct 2015, Accepted 08 Mar 2016, Published online: 13 Apr 2016

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Katsuhiro Miura, Noriyoshi Iriyama, Yoshihiro Hatta & Masami Takei. (2021) Personalized patient care with aggressive hematological malignancies in non-responders to first-line treatment. Expert Review of Precision Medicine and Drug Development 6:3, pages 203-215.
Read now

Articles from other publishers (11)

Hiromichi Takahashi, Haruna Nishimaki, Yoko Nakanishi, Takashi Hamada, Masaru Nakagawa, Kazuhide Iizuka, Yoshihito Uchino, Noriyoshi Iriyama, Katsuhiro Miura, Tomohiro Nakayama, Shinobu Masuda, Yoshihiro Hatta & Hideki Nakamura. (2022) Clinical impact of central nervous system‐directed therapies on intravascular large B‐cell lymphoma: A single institution's experience. eJHaem 3:2, pages 467-470.
Crossref
Zhongrui Li, Lan Zhang, Dongrui Liu, Zhanghui Yang, Di Xuan & Yi Zhang. (2022) Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA/Myc/Bcl2 axis. Cell Death Discovery 8:1.
Crossref
Jayalakshmi Balakrishna, Jesse Kulewsky & Anil Parwani. (2022) A digital method to interpret the C-MYC stain in diffuse large B cell lymphoma. Journal of Pathology Informatics 13, pages 100100.
Crossref
Christopher R. D’Angelo, Walter Hanel, Yi Chen, Menggang Yu, David Yang, Ling Guo, Reem Karmali, Madelyn Burkart, Colleen Ciccosanti, Kevin David, Zachary Risch, Carlos Murga‐Zamalloa, Sumana Devata, Ryan Wilcox, Malvi Savani, Elizabeth L. Courville, Veronika Bachanova, Emma Rabinovich, David Peace, Fauzia Osman, Narendranath Epperla & Vaishalee P. Kenkre. (2021) Impact of initial chemotherapy regimen on outcomes for patients with double‐expressor lymphoma: A multi‐center analysis. Hematological Oncology 39:4, pages 473-482.
Crossref
Marjukka Pollari, Suvi-Katri Leivonen & Sirpa Leppä. (2021) Testicular Diffuse Large B-Cell Lymphoma—Clinical, Molecular, and Immunological Features. Cancers 13:16, pages 4049.
Crossref
Jisun Hwang, Chong Suh, Kyung Kim, Ho Kim, Austin Kim, Jeffrey Craig, Ke Chen, Joel Roberson, Jeffrey Guenette & Raymond Huang. (2021) The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis. Cancers 13:13, pages 3369.
Crossref
Bogyeong Han, Sehui Kim, Jiwon Koh, Jeemin Yim, Cheol Lee, Dae Seog Heo, Tae Min Kim, Jin Ho Paik & Yoon Kyung Jeon. (2020) Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled Cohort. Cancers 12:11, pages 3305.
Crossref
Victor Bobée, Fanny Drieux, Vinciane Marchand, Vincent Sater, Liana Veresezan, Jean-Michel Picquenot, Pierre-Julien Viailly, Marie-Delphine Lanic, Mathieu Viennot, Elodie Bohers, Lucie Oberic, Christiane Copie-Bergman, Thierry Jo Molina, Philippe Gaulard, Corinne Haioun, Gilles Salles, Hervé Tilly, Fabrice Jardin & Philippe Ruminy. (2020) Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma. Blood Cancer Journal 10:5.
Crossref
Joel C. Wight, Geoffrey Chong, Andrew P. Grigg & Eliza A. Hawkes. (2018) Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Reviews 32:5, pages 400-415.
Crossref
Pierre Sesques & Nathalie A. Johnson. (2017) Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements. Blood 129:3, pages 280-288.
Crossref
D. Alan Potts, Jonathan R. Fromm, Ajay K. Gopal & Ryan D. Cassaday. (2017) Spontaneous Remission of an Untreated, MYC and BCL2 Coexpressing, High-Grade B-Cell Lymphoma: A Case Report and Literature Review. Case Reports in Hematology 2017, pages 1-6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.